NewEdge Advisors, LLC

Position in BEAM — Beam Therapeutics Inc.

CIK 1633516 NEW ORLEANS, LA

Position in BEAM

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$8,065

+$82 QoQ

Shares Held

235

-29.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#233

of 274 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

NewEdge Advisors, LLC holds $47,755,733 across 102 Biotechnology names. BEAM ranks #63 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	18,435	$9,157,217
2	REGN	Regeneron Pharmaceuticals, Inc.	11,911	$7,426,984
3	NUVB	Nuvation Bio Inc.	1,231,733	$6,996,243
4	INCY	Incyte Corp	34,605	$3,922,822
5	PHAT	Phathom Pharmaceuticals, Inc.	203,962	$2,212,987
6	EXEL	Exelixis, Inc.	32,532	$1,770,066
7	BMRN	Biomarin Pharmaceutical Inc	27,287	$1,561,362
8	RPRX	Royalty Pharma plc	21,597	$1,210,943

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,065	235	-29.9%	Shares	Sole	2026-08-12
2026-03-31	$7,983	335	0.0%	Shares	Sole	2026-06-03
2025-12-31	$9,286	335	-46.1%	Shares	Sole	2026-02-18
2025-09-30	$15,071	621	0.0%	Shares	Sole	2025-11-17
2025-06-30	$10,563	621	-13.9%	Shares	Sole	2025-08-14
2025-03-31	$14,081	721	+208.1%	Shares	Sole	2025-05-15
2024-12-31	$5,803	234	-41.4%	Shares	Sole	2025-02-13
2024-09-30	$9,775	399	0.0%	Shares	Sole	2024-11-14
2024-06-30	$9,348	399	-9.7%	Shares	Sole	2024-08-16
2024-03-31	$14,603	442	+10.8%	Shares	Sole	2024-05-14
2023-12-31	$10,860	399	-1.0%	Shares	Sole	2024-02-13
2023-09-30	$9,692	403	0.0%	Shares	Sole	2023-11-14
2023-06-30	$12,867	403	-62.3%	Shares	Sole	2023-08-14
2023-03-31	$32,763	1,070	-23.4%	Shares	Sole	2023-05-12
2022-12-31	$54,636	1,397	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.